STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis
USA - NYSE:STVN - IT0005452658 - Common Stock
24.9 USD
+0.16 (+0.65%)
We assign a fundamental rating of 5 out of 10 to STVN. STVN was compared to 58 industry peers in the Life Sciences Tools & Services industry. While STVN has a great profitability rating, there are some minor concerns on its financial health. STVN is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
STVN had positive earnings in the past year.
In the past year STVN had a positive cash flow from operations.
Each year in the past 5 years STVN has been profitable.
In the past 5 years STVN always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 5.72%, STVN belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
The Return On Equity of STVN (9.63%) is better than 81.03% of its industry peers.
With a decent Return On Invested Capital value of 7.90%, STVN is doing good in the industry, outperforming 79.31% of the companies in the same industry.
STVN had an Average Return On Invested Capital over the past 3 years of 9.71%. This is below the industry average of 13.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.72% | ||
| ROE | 9.63% | ||
| ROIC | 7.9% |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
1.3 Margins
The Profit Margin of STVN (11.75%) is better than 81.03% of its industry peers.
In the last couple of years the Profit Margin of STVN has grown nicely.
With an excellent Operating Margin value of 17.17%, STVN belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
STVN's Operating Margin has improved in the last couple of years.
The Gross Margin of STVN (28.83%) is worse than 74.14% of its industry peers.
STVN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.17% | ||
| PM (TTM) | 11.75% | ||
| GM | 28.83% |
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), STVN is creating some value.
Compared to 1 year ago, STVN has more shares outstanding
Compared to 5 years ago, STVN has less shares outstanding
STVN has a better debt/assets ratio than last year.
2.2 Solvency
STVN has an Altman-Z score of 5.47. This indicates that STVN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of STVN (5.47) is better than 82.76% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that STVN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.24, STVN is in line with its industry, outperforming 53.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.47 |
ROIC/WACC0.94
WACC8.4%
2.3 Liquidity
STVN has a Current Ratio of 1.79. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, STVN is in line with its industry, outperforming 43.10% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that STVN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.22, STVN is not doing good in the industry: 70.69% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.00% over the past year.
STVN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.29% yearly.
STVN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.28%.
The Revenue has been growing by 15.53% on average over the past years. This is quite good.
EPS 1Y (TTM)4%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%22.22%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%7.86%
3.2 Future
The Earnings Per Share is expected to grow by 17.54% on average over the next years. This is quite good.
Based on estimates for the next years, STVN will show a small growth in Revenue. The Revenue will grow by 7.87% on average per year.
EPS Next Y11.52%
EPS Next 2Y17.73%
EPS Next 3Y19.74%
EPS Next 5Y17.54%
Revenue Next Year6.98%
Revenue Next 2Y8.54%
Revenue Next 3Y9.28%
Revenue Next 5Y7.87%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 41.50 indicates a quite expensive valuation of STVN.
Based on the Price/Earnings ratio, STVN is valued a bit cheaper than the industry average as 60.34% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.03, STVN is valued quite expensively.
STVN is valuated quite expensively with a Price/Forward Earnings ratio of 32.57.
Compared to the rest of the industry, the Price/Forward Earnings ratio of STVN indicates a somewhat cheap valuation: STVN is cheaper than 65.52% of the companies listed in the same industry.
STVN's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.5 | ||
| Fwd PE | 32.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STVN indicates a somewhat cheap valuation: STVN is cheaper than 77.59% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 22.42 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates STVN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of STVN may justify a higher PE ratio.
A more expensive valuation may be justified as STVN's earnings are expected to grow with 19.74% in the coming years.
PEG (NY)3.6
PEG (5Y)1.52
EPS Next 2Y17.73%
EPS Next 3Y19.74%
5. Dividend
5.1 Amount
With a yearly dividend of 0.25%, STVN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.49, STVN pays a better dividend. On top of this STVN pays more dividend than 82.76% of the companies listed in the same industry.
With a Dividend Yield of 0.25, STVN pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
5.2 History
STVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
STVN pays out 10.74% of its income as dividend. This is a sustainable payout ratio.
DP10.74%
EPS Next 2Y17.73%
EPS Next 3Y19.74%
NYSE:STVN (11/5/2025, 3:50:48 PM)
24.9
+0.16 (+0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners111.37%
Inst Owner Change1.58%
Ins Owners1.61%
Ins Owner ChangeN/A
Market Cap6.80B
Revenue(TTM)1.15B
Net Income(TTM)134.56M
Analysts83.53
Price Target29.69 (19.24%)
Short Float %4.7%
Short Ratio6.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.74%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)2.71%
Max EPS beat(2)10.28%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-7.68%
Max EPS beat(4)10.28%
EPS beat(8)3
Avg EPS beat(8)-5.73%
EPS beat(12)6
Avg EPS beat(12)-2.97%
EPS beat(16)10
Avg EPS beat(16)0.11%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.72%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)2.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)6.26%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)-7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-2.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.5 | ||
| Fwd PE | 32.57 | ||
| P/S | 5.16 | ||
| P/FCF | N/A | ||
| P/OCF | 28.63 | ||
| P/B | 4.23 | ||
| P/tB | 4.5 | ||
| EV/EBITDA | 22.42 |
EPS(TTM)0.6
EY2.41%
EPS(NY)0.76
Fwd EY3.07%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.87
OCFY3.49%
SpS4.82
BVpS5.89
TBVpS5.53
PEG (NY)3.6
PEG (5Y)1.52
Graham Number8.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.72% | ||
| ROE | 9.63% | ||
| ROCE | 10.51% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.32% | ||
| ROICexgc | 8.73% | ||
| OM | 17.17% | ||
| PM (TTM) | 11.75% | ||
| GM | 28.83% | ||
| FCFM | N/A |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexgc growth 3Y-28.59%
ROICexgc growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 338.93% | ||
| Cap/Sales | 23.63% | ||
| Interest Coverage | 22.83 | ||
| Cash Conversion | 74.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.47 |
F-Score5
WACC8.4%
ROIC/WACC0.94
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%22.22%
EPS Next Y11.52%
EPS Next 2Y17.73%
EPS Next 3Y19.74%
EPS Next 5Y17.54%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%7.86%
Revenue Next Year6.98%
Revenue Next 2Y8.54%
Revenue Next 3Y9.28%
Revenue Next 5Y7.87%
EBIT growth 1Y6.16%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year71.18%
EBIT Next 3Y33.24%
EBIT Next 5Y23.69%
FCF growth 1Y70.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.91%
OCF growth 3Y5.33%
OCF growth 5Y29.6%
STEVANATO GROUP SPA / STVN FAQ
What is the ChartMill fundamental rating of STEVANATO GROUP SPA (STVN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to STVN.
Can you provide the valuation status for STEVANATO GROUP SPA?
ChartMill assigns a valuation rating of 2 / 10 to STEVANATO GROUP SPA (STVN). This can be considered as Overvalued.
How profitable is STEVANATO GROUP SPA (STVN) stock?
STEVANATO GROUP SPA (STVN) has a profitability rating of 7 / 10.
What are the PE and PB ratios of STEVANATO GROUP SPA (STVN) stock?
The Price/Earnings (PE) ratio for STEVANATO GROUP SPA (STVN) is 41.5 and the Price/Book (PB) ratio is 4.23.
What is the earnings growth outlook for STEVANATO GROUP SPA?
The Earnings per Share (EPS) of STEVANATO GROUP SPA (STVN) is expected to grow by 11.52% in the next year.